Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Computing & Software • Transportation, E-Commerce & Mechanical Systems
5 pending office actions • 5 clients • 5 examiners • 3 art units • 0 of 5 (0%) have an AI response strategy ready
BUCKINGHAM, DOOLITTLE & BURROUGHS, LLC has processed 746 career applications in Biotechnology & Pharmaceuticals. The firm maintains a resolved allowance rate of 87.61 percent. This indicates a high success rate in a traditionally complex technology area.
The firm currently has 3 pending office actions. On average, the firm receives 2.88 office actions per allowance. This metric suggests a relatively efficient prosecution process, requiring this specific volume of interactions with examiners on average to secure an allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (20%) |
| §101 + other | 2 (40%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GUSTILO, ESTELLA M | 1 | 53.6% | +34.5% |
| RAJAPUTRA, SUMAN | 1 | 69.5% | +37.5% |
| CRANDALL, RICHARD W. | 1 | 30.2% | +33.8% |
| GEBRESILASSIE, KIBROM K | 1 | 72.3% | +25.8% |
| WESTERBERG, NISSA M | 1 | 23.4% | +37.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691296 | RNA Vaccine Comprising an RNA Pool Generated From a Double-Stranded DNA Pool | GUSTILO, ESTELLA M | — |
| 18568355 | N-HAMMING DISTANCE SEARCH AND N-HAMMING DISTANCE SEARCH INDEX | RAJAPUTRA, SUMAN | — |
| 18130723 | SOLAR PANEL INSTALLATION DESIGN PROGRAM | GEBRESILASSIE, KIBROM K | — |
| 17435832 | USE OF EPALRESTAT IN PREPARATION OF PANCREATIC CANCER DRUGS AND METHOD FOR VERIFYING INHIBITION EFFECT OF EPALRESTAT ON SECRETION OF EXOSOMES FROM PANCREATIC CANCER CELLS | WESTERBERG, NISSA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691296 | RNA Vaccine Comprising an RNA Pool Generated From a Double-Stranded DNA Pool | GUSTILO, ESTELLA M | — |
| 18568355 | N-HAMMING DISTANCE SEARCH AND N-HAMMING DISTANCE SEARCH INDEX | RAJAPUTRA, SUMAN | — |
| 18233781 | MEDIATED ANONYMOUS NEGOTIATION SYSTEM | CRANDALL, RICHARD W. | — |
| 18130723 | SOLAR PANEL INSTALLATION DESIGN PROGRAM | GEBRESILASSIE, KIBROM K | — |
| 17435832 | USE OF EPALRESTAT IN PREPARATION OF PANCREATIC CANCER DRUGS AND METHOD FOR VERIFYING INHIBITION EFFECT OF EPALRESTAT ON SECRETION OF EXOSOMES FROM PANCREATIC CANCER CELLS | WESTERBERG, NISSA M | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Oncodna | 1 |
| Voredos | 1 |
| Sunhub LLC | 1 |
| Logically Engineered Automation Features Ltd. | 1 |
| AFFILIATED HOSPITAL OF NANTONG UNIVERSITY | 1 |
| Art Unit | Apps |
|---|---|
| 2163 | 1 |
| 3619 | 1 |
| 1618 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18691296 | RNA Vaccine Comprising an RNA Pool Generated From a Double-Stranded DNA Pool | Oncodna | GUSTILO, ESTELLA M | §101§102§112DP | Non-Final OA | — | Pending | Mar 12, 2024 | |
| 18568355 | N-HAMMING DISTANCE SEARCH AND N-HAMMING DISTANCE SEARCH INDEX | Voredos | RAJAPUTRA, SUMAN | 2163 | §101§103 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18233781 | MEDIATED ANONYMOUS NEGOTIATION SYSTEM | Sunhub LLC | CRANDALL, RICHARD W. | 3619 | §103 | Final Rejection | — | Pending | Aug 14, 2023 |
| 18130723 | SOLAR PANEL INSTALLATION DESIGN PROGRAM | Logically Engineered Automation Features Ltd. | GEBRESILASSIE, KIBROM K | §101 | Non-Final OA | — | Pending | Apr 04, 2023 | |
| 17435832 | USE OF EPALRESTAT IN PREPARATION OF PANCREATIC CANCER DRUGS AND METHOD FOR VERIFYING INHIBITION EFFECT OF EPALRESTAT ON SECRETION OF EXOSOMES FROM PANCREATIC CANCER CELLS | Affiliated Hospital Of Nantong University | WESTERBERG, NISSA M | 1618 | §112 | Final Rejection | — | Pending | Sep 02, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial